Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $0.32 in the prior trading day, GlycoMimetics Inc (NASDAQ: GLYC) closed at $0.32, down -1.00%. In other words, the price has decreased by -$1.00 from its previous closing price. On the day, 0.64 million shares were traded. GLYC stock price reached its highest trading level at $0.35 during the session, while it also had its lowest trading level at $0.3113.
Ratios:
Our goal is to gain a better understanding of GLYC by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.62 and its Current Ratio is at 3.62. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.00.
On December 22, 2023, CapitalOne started tracking the stock assigning a Overweight rating and target price of $12.
Jefferies Upgraded its Hold to Buy on November 12, 2021, whereas the target price for the stock was revised from $3 to $4.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 08 ’24 when Invus Public Equities, L.P. sold 260,873 shares for $0.19 per share. The transaction valued at 50,009 led to the insider holds 6,317,565 shares of the business.
Invus Public Equities, L.P. sold 61,488 shares of GLYC for $11,197 on Aug 07 ’24. The 10% Owner now owns 6,578,438 shares after completing the transaction at $0.18 per share. On Aug 05 ’24, another insider, Invus Public Equities, L.P., who serves as the 10% Owner of the company, sold 164,523 shares for $0.19 each. As a result, the insider received 30,996 and left with 6,695,658 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GLYC now has a Market Capitalization of 20428532 and an Enterprise Value of 3817615. For the stock, the TTM Price-to-Sale (P/S) ratio is 2022.57 while its Price-to-Book (P/B) ratio in mrq is 1.80. Its current Enterprise Value per Revenue stands at 381.762 whereas that against EBITDA is -0.094.
Stock Price History:
Over the past 52 weeks, GLYC has reached a high of $3.53, while it has fallen to a 52-week low of $0.14. The 50-Day Moving Average of the stock is 26.35%, while the 200-Day Moving Average is calculated to be -66.51%.
Shares Statistics:
The stock has traded on average 19.26M shares per day over the past 3-months and 1615380 shares per day over the last 10 days, according to various share statistics. A total of 64.39M shares are outstanding, with a floating share count of 57.07M. Insiders hold about 11.50% of the company’s shares, while institutions hold 37.47% stake in the company. Shares short for GLYC as of 1730332800 were 5638593 with a Short Ratio of 0.29, compared to 1727654400 on 1637061. Therefore, it implies a Short% of Shares Outstanding of 5638593 and a Short% of Float of 12.61.
